ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $611,000 | +4.1% | 23,787 | +5.6% | 0.20% | -0.5% |
Q2 2021 | $587,000 | -8.7% | 22,518 | +23.7% | 0.20% | -21.4% |
Q1 2021 | $643,000 | +60.0% | 18,208 | +14.5% | 0.25% | +44.0% |
Q4 2020 | $402,000 | -5.2% | 15,909 | +9.4% | 0.18% | -12.5% |
Q3 2020 | $424,000 | – | 14,547 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |